FDA unveils plan to boost diversity in clinical trials

Original Article by Manas Mishra & Bhanvi Satija | Reuters | 26 June 2024

The FDA's draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.

The FDA’s draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here